Porcine neural cell product-FE

Drug Profile

Porcine neural cell product-FE

Alternative Names: Neurocell-FE

Latest Information Update: 30 Jul 2004

Price : $50

At a glance

  • Originator GenVec
  • Class Antiepileptic drugs; Neuroprotectants
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Epilepsy

Most Recent Events

  • 30 Jul 2004 Discontinued - Phase-I for Epilepsy in USA (Intracerebal)
  • 26 Aug 2003 Diacrin has been acquired by, and merged into, GenVec
  • 29 Aug 2002 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top